Ausgabe 3/2024
Inhalt (20 Artikel)
Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies
C. Florin Pop, Isabelle Veys, Anne Bormans, Denis Larsimont, Gabriel Liberale
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis
Deniz Can Guven, Taha Koray Sahin
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma
Saki Nakagawa, Minoru Miyashita, Ichiro Maeda, Atsushi Goda, Hiroshi Tada, Masakazu Amari, Yasuyuki Kojima, Koichiro Tsugawa, Yasuyo Ohi, Yasuaki Sagara, Miku Sato, Akiko Ebata, Narumi Harada-Shoji, Takashi Suzuki, Makoto Nakanishi, Tomohiko Ohta, Takanori Ishida
Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression
Fan Zhang, Yue Xu, Jiediao Lin, Hongchao Pan, Armando E. Giuliano, Xiaojiang Cui, Yukun Cui
Integrated analysis of diverse cancer types reveals a breast cancer-specific serum miRNA biomarker through relative expression orderings analysis
Liyuan Ma, Yaru Gao, Yue Huo, Tian Tian, Guini Hong, Hongdong Li
Effectiveness and toxicity of five-fraction prone accelerated partial breast irradiation
Camille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, David Barbee, Bhartesh Shah, Olivier Maisonet, Carmen Perez, Sylvia Adams, Freya Schnabel, Deborah Axelrod, Amber Guth, Nolan Karp, Oren Cahlon, Naamit Gerber
Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome
Annemiek van Hemert, Ariane A. van Loevezijn, Anne Bosman, Carmen A. Vlahu, Claudette E. Loo, Marie-Jeanne T. F. D. Vrancken Peeters, Frederieke H. van Duijnhoven, Iris M. C. van der Ploeg
Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer
Saumya Umashankar, Moming Li, Kaylee Blevins, Mi-Ok Kim, Melanie Majure, John Park, Laura A. Huppert, Michelle Melisko, Hope S. Rugo, Laura Esserman, A. Jo Chien
The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer
Ingrid V. Bonilla Valente, Denise Garcia, Andrea Abbott, Laura Spruill, Julie Siegel, Jessica Forcucci, George Hanna, Rupak Mukherjee, Mark Hamann, Eleanor Hilliard, Mark Lockett, David J. Cole, Nancy Klauber-DeMore
The COVID-19 pandemic and its effects on follow-up of patients with early breast cancer: A patient survey
Ana-Alicia Beltran-Bless, Gail Larocque, Muriel Brackstone, Angel Arnaout, Jean-Michel Caudrelier, Denise Boone, Parvaneh Fallah, Terry Ng, Peter Cross, Nasser Alqahtani, John Hilton, Lisa Vandermeer, Gregory Pond, Mark Clemons
Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer
Elizabeth Joyce, Xueting Tao, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo, Kelley M. Kidwell, N. Lynn Henry
Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial
Emily A. Walsh, Kathryn Post, Katina Massad, Nora Horick, Michael H. Antoni, Frank J. Penedo, Steven A. Safren, Ann H. Partridge, Jeffrey Peppercorn, Elyse R. Park, Jennifer S. Temel, Joseph A. Greer, Jamie M. Jacobs
Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors
Ching-Yuan Chang, Bobby L. Jones, Juan M. Hincapie-Castillo, Haesuk Park, Coy D. Heldermon, Vakaramoko Diaby, Debbie L. Wilson, Wei-Hsuan Lo-Ciganic
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database
Stephanie H. Read, Nadia Quignot, Raissa Kapso-Kapnang, Erin Comerford, Ying Zheng, Corona Gainford, Medha Sasane, Anne-Lise Vataire, Laure Delzongle, Francois-Clement Bidard
Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial
Haiyun Wang, Douglas Yee, David Potter, Patricia Jewett, Christina Yau, Heather Beckwith, Allison Watson, Nicholas O’Grady, Amy Wilson, Susie Brain, Paula Pohlmann, Anne Blaes
Factors influencing the first and the fifth years adherence to adjuvant endocrine therapy in breast cancer patients in a low income country
Antonio Pedro Nicoletti, Andrea P Damin
Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer
Maria Eleni Hatzipanagiotou, Miriam Pigerl, Michael Gerken, Sophie Räpple, Verena Zeltner, Madeleine Hetterich, Peter Ugocsai, Elisabeth Christine Inwald, Monika Klinkhammer-Schalke, Olaf Ortmann, Stephan Seitz
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer
Jianxin Zhong, Hanfang Jiang, Xiaoran Liu, Hao Liao, Feng Xie, Bin Shao, Shidong Jia, Huiping Li
Endosomal recycling inhibitors downregulate estrogen receptor-alpha and synergise with endocrine therapies
Kelsey A. Fletcher, Mai H. Alkurashi, Andrew J. Lindsay
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors
Alexander S. Bang, Christopher J. Fay, Nicole R. LeBoeuf, Farshid Etaee, Jonathan S. Leventhal, Vincent Sibaud, Joshua Arbesman, Jennifer Y. Wang, Bernice Y. Kwong